CalciMedica, Inc.: CVI Investments, Inc. amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
CVI Investments, Inc. amended its Schedule 13G filing on CalciMedica, Inc., updating its beneficial ownership stake with the SEC under accession number 0001649553-26-000142. The amendment signals a change in the investor's position in the clinical-stage biopharmaceutical company, though the filing did not disclose the specific size of the stake or the direction of the change. Schedule 13G amendments are typically filed by passive investors and are closely watched for signs of shifting institutional interest in small-cap biotech names. Investors will look to the amended filing for details on CVI's current ownership percentage and any change from its prior reported position.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
CalciMedica, Inc., CVI Investments, Inc.